Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer.
Bayou N, Henretta S, Munoz-Arcos L, Molteni E, Gianni C, Serafini MS, Nicolò E, Pontolillo L, Pasto B, Gaudio HA, Manai M, Afghan MMK, Manohar J, Elemento O, Andreopoulou E, Cristofanilli M, Reduzzi C.
Bayou N, et al. Among authors: henretta s.
Cancer Cell Int. 2025 Dec 24;25(1):439. doi: 10.1186/s12935-025-04036-x.
Cancer Cell Int. 2025.
PMID: 41444606
Free PMC article.